CASPOFUNGIN Viatris subst sèche 50 mg flac
7680671860030
CH-67186
J02AX04
08.06.0.
Reimbursement limitations:
CANCIDAS
Traitement de l'aspergillose invasive chez les patients réfractaires ou intolérants à d'autres traitements (l'amphotéricine B, …
1 / 3
google
Details
- Product number
- 6718601
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: caspofunginum 50 mg ut caspofungini diacetas, saccharum, mannitolum, carbonei dioxidum, acidum hydrochloridum concentratum, natrii hydroxidum corresp. natrium 0.39 mg, pro vitro.
Articles (1)
Caspofungin Viatris 50 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | WIZUS |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
0.36 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 304.75
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/11/2019
Authorization holder
Viatris Pharma GmbH
6312 Steinhausen
Authorization information
- Swissmedic authorization number
- 67186
- Drug name
- Caspofungin Viatris, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- PULPI
- ATC Code
- J02AX04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 19/07/2019
- Authorization expiration date
- 31/12/9999
- IT number
- 08.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CASPOFUNGIN Viatris subst sèche 50 mg flac
- Description (DE)
- CASPOFUNGIN Viatris Trockensub 50 mg Durchstf
- Market launch
- 19/07/2019
- Narcotic (BTM)
- No
Original drug
Cancidas, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
GTIN:
7680555840011
CHF 475.20